Perspectives on meningoencephalomyelitis of unknown origin

Veterinary Clinics of North America - Small Animal Practice

Volumn 44, Issue 6, 2014, Pages 1157-1185

  Coates, Joan R ^a   Jeffery, Nicholas D ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Central nervous system; Granulomatous meningoencephalomyelitis; Immune mediated; Immunomodulation; Inflammatory; Necrotizing leukoencephalitis; Necrotizing meningoencephalitis

Indexed keywords

ARABINOSIDE; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOSINE; LEFLUNOMIDE; LOMUSTINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROCARBAZINE; VINCRISTINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; BRAIN BIOPSY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENCEPHALITIS; ENCEPHALOMYELITIS; GENETIC ASSOCIATION; GENETIC SCREENING; GRANULOMATOUS INFLAMMATION; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE ACTIVATION; MENINGOENCEPHALITIS; MENINGOENCEPHALOMYELITIS OF UNKNOWN ORIGIN; MICROGLIA; NECROTIZING ENCEPHALITIS; NECROTIZING LEUKOENCEPHALITIS; NECROTIZING MENINGOENCEPHALITIS; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; ANIMAL; DOG; DOG DISEASES; PATHOLOGY; VETERINARY;

ANIMALS; DOG DISEASES; DOGS; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; MENINGOENCEPHALITIS;

EID: 84908547850     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2014.07.009     Document Type: Review

References (162)

1. Higgins R.J., Dickinson P.J., Kube S.A., et al. Necrotizing meningoencephalitis in five chihuahua dogs. Vet Pathol 2008, 45:336-346.
2. Higgins RJ, LeCouteur RA. GME, NME, and breed specific encephalitis and allied disorders: Variations of the same theme or different diseases? A clinical and pathological perspective. 20th Annual Symposium of the European College of Veterinary Neurology. Bern (Switzerland), September 27-29, 2007. p. 35-7.
3. Cooper J.J., Schatzberg S.J., Vernau K.M., et al. Necrotizing meningoencephalomyelitis in atypical dog breeds: a case series and literature review. JVet Intern Med 2014, 28:198-203.
4. Talarico L.R., Schatzberg S.J. Idiopathic granulomatous and necrotising inflammatory disorders of the canine central nervous system: a review and future perspectives. JSmall Anim Pract 2010, 51:138-149.
5. Thomas J.B., Eger C. Granulomatous meningoencephalomyelitis in 21 dogs. JSmall Anim Pract 1989, 30:287-293.
6. Kipar A., Baumgartner W., Vogl C., et al. Immunohistochemical characterization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis. Vet Pathol 1998, 35:43-52.
7. Schwab S., Herden C., Seeliger F., et al. Non-suppurative meningoencephalitis of unknown origin in cats and dogs: an immunohistochemical study. JComp Pathol 2007, 136:96-110.
8. Schatzberg S.J., Haley N.J., Barr S.C., et al. Polymerase chain reaction screening for DNA viruses in paraffin-embedded brains from dogs with necrotizing meningoencephalitis, necrotizing leukoencephalitis, and granulomatous meningoencephalitis. JVet Intern Med 2005, 19:553-559.
9. Barber R.M., Li Q., Diniz P.P., et al. Evaluation of brain tissue or cerebrospinal fluidwith broadly reactive polymerase chain reaction for Ehrlichia, Anaplasma, spotted fever group Rickettsia, Bartonella, and Borrelia species in canine neurological diseases (109 cases). JVet Intern Med 2010, 24:372-378.
10. Barber R.M., Porter B.F., Li Q., et al. Broadly reactive polymerase chain reaction for pathogen detection in canine granulomatous meningoencephalomyelitis and necrotizing meningoencephalitis. JVet Intern Med 2012, 26:962-968.
11. Matsuki N., Fujiwara K., Tamahara S., et al. Prevalence of autoantibody in cerebrospinal fluids from dogs with various CNS diseases. JVet Med Sci 2004, 66:295-297.
12. Greer K.A., Wong A.K., Liu H., et al. Necrotizing meningoencephalitis of pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis. Tissue Antigens 2010, 76:110-118.
13. Tsunoda I., Kuang L.Q., Theil D.J., et al. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol 2000, 10:402-418.
14. Kipnis J., Yoles E., Schori H., et al. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. JNeurosci 2001, 21:4564-4571.
15. Kipnis J., Mizrahi T., Hauben E., et al. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA 2002, 99:15620-15625.
16. Tipold A. Diagnosis of inflammatory and infectious diseases of the central nervous system in dogs: a retrospective study. JVet Intern Med 1995, 9:304-314.
17. Zarfoss M., Schatzberg S., Venator K., et al. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs. JSmall Anim Pract 2006, 47:588-595.
18. Tipold A., Vandevelde M., Schatzberg S.J. Necrotizing encephalitis. Infectious diseases of the dog and cat 2012, 856-858. Elsevier, St Louis (MO). 4th edition. C.E. Greene (Ed.).
19. Cardoso R., Brites D., Brito M.A. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev 2010, 64:328-364.
20. Engelhardt B., Sorokin L. The blood-brain and the blood-CSF barriers: function and dysfunction. Semin Immunopathol 2009, 31:497-511.
21. Abbott N.J., Ronnback L., Hansson E., et al. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
22. Carson M.J., Doose J.M., Melchior B., et al. CNS immune privilege: hiding in plain sight. Immunol Rev 2006, 213:48-65.
23. Lyman M., Lloyd D.G., Sunming J., et al. Neuroinflammation: the role and consequences. Neurosci Res 2014, 79:1-12.
24. Abbas A.K., Lichtman A.H., Pillai S. Cellular and molecular immunology 2012, Elsevier, St Louis (MO).
25. Gershwin L.J. Autoimmune diseases in small animals. Vet Clin North Am Small Anim Pract 2010, 40(3):439-457.
26. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581.
27. Lyck R., Engelhardt B. Going against the tide - how encephalitogenic T cells breach the blood-brain barrier. JVasc Res 2012, 49:497-509.
28. Smith J.A., Das A., Ray S.K., et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012, 87:10-20.
29. Kierschensteiner M., Meinl E., Holfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009, 158:1122-1132.
30. Hendrix S., Nitsch R. The role of T helper cells in neuroprotection and regeneration. JNeuroimmunol 2007, 184:100-112.
31. Wang C.X., Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002, 67:161-172.
32. Sokolova A., Hill M.D., Rahimi F., et al. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol 2009, 19:392-398.
33. Cardona A.E., Pioro E.P., Sasse M.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 2006, 9:917-924.
34. Carr M.W., Roth S.J., Luther E., et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994, 91:3652-3656.
35. Taub D.D., Proost P., Murphy W.J., et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. JClin Invest 1995, 95:1370-1376.
36. Neumann H., Wekerle H. Brain microglia: watchdogs with pedigree. Nat Neurosci 2013, 16:253-255.
37. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27:119-145.
38. Biber K., Owens T., Boddeke E. What is microglia neurotoxicity (not?). Glia 2014, 62:841-854.
39. Carson M.J., Bilousova T.V., Puntambekar S.S., et al. Arose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 2007, 4:571-579.
40. Suzumura A. Neuron-microglia interaction in neuroinflammation. Curr Protein Pept Sci 2013, 14:16-20.
41. Michelucci A., Heurtaux T., Grandbarbe L., et al. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. JNeuroimmunol 2009, 210:3-12.
42. Geissmann F., Auffray C., Palframan R., et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of Tcell responses. Immunol Cell Biol 2008, 86:398-408.
43. Martinez F.O., Sica A., Mantovani A., et al. Macrophage activation and polarization. Front Biosci 2008, 13:453-461.
44. Dheen S.T., Kaur C., Ling E.A. Microglial activation and its implications in the brain diseases. Curr Med Chem 2007, 14:1189-1197.
45. Benoit M., Benoit D., Mege J.L. Macrophage polarization in bacterial infections. JImmunol 2008, 181:3733-3739.
46. Schwartz M., Butovsky O., Bruck W., et al. Microglial phenotype: is the commitment reversible. Trends Neurosci 2006, 29:68-74.
47. Stein V.M., Puff C., Genini S., et al. Variations on brain microglial gene expression of MMPs, RECK and TIMPs in inflammatory and non-inflammatory diseases in dogs. Vet Immunol Immunopathol 2011, 144:17-26.
48. Stein V.M., Baumgartner W., Kreienbrock L., et al. Canine microglial cells: stereotypy in immunophenotype and specificity in function?. Vet Immunol Immunopathol 2006, 113:277-287.
49. Boekhoff T.M., Ensinger E.M., Calrson R., et al. Microglial contribution to secondary injury evaluated in a large animal model of human spinal cord trauma. JNeurotrauma 2012, 29:1000-1011.
50. Stein V.M., Czub M., Hansen R., et al. Characterization of canine microglial cells isolated exvivo. Vet Immunol Immunopathol 2004, 99:73-85.
51. Ensinger E.M., Boekhoff T.M., Carlson R., et al. Regional topographical differences of canine microglial immunophenotype and function in the healthy spinal cord. JNeuroimmunol 2010, 227:144-152.
52. Spitzbarth I., Baumgartner W., Beineke A. The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine diseases. Vet Immunol Immunopathol 2012, 147:6-24.
53. Beineke A., Markus S., Borlak J., et al. Increase of pro-inflammatory cytokine expression in non-demyelinating early cerebral lesions in nervous canine distemper. Viral Immunol 2008, 21:401-410.
54. Beineke A., Puff C., Seehusen F., et al. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 2009, 127:1-18.
55. Appel S.H., Beers D.R., Henkel J.S. Tcell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?. Trends Immunol 2009, 31:7-17.
56. Schwartz M., Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. JNeurol Sci 2005, 233:163-166.
57. Griffin J.F., Levine J.M., Levine G.J., et al. Meningomyelitis in dogs: a retrospective review of 28 cases (1999-2007). JSmall Anim Pract 2008, 49:509-517.
58. Granger N., Smith P.M., Jeffery N.D. Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008. Vet J 2010, 184:290-297.
59. Sorjonen D.C. Clinical and histopathological features of granulomatous meningoencephalomyelitis in dogs. JAm Anim Hosp Assoc 1990, 26:141-147.
60. Braund K.G. Granulomatous meningoencephalitis. JAm Vet Med Assoc 1985, 186:138-141.
61. Russo M.E. Primary reticulosis of the central nervous system in dogs. JAm Vet Med Assoc 1979, 174:492-500.
62. Munana K.R., Luttgen P.J. Prognostic factors for dogs with granulomatous meningoencephalomyelitis: 42 cases (1982-1996). JAm Vet Med Assoc 1998, 212:1902-1906.
63. Fischer C.A., Liu S.K. Neuro-ophthalmologic manifestations of primary reticulosis of the central nervous system in a dog. JAm Vet Med Assoc 1971, 158:1240-1248.
64. Smith J., DeLahunta A., Riss R. Reticulosis of the visual system in a dog. JSmall Anim Pract 1977, 18:643-652.
65. Garmer N., Naeser P., Bergman A. Reticulosis of the eyes and the central nervous system in a dog. JSmall Anim Pract 1981, 22:39-45.
66. Cuddon P.A., Smith-Maxie L. Reticulosis of the central nervous system in the dog. Compend Contin Educ Vet Prac 1984, 6:23-32.
67. Kitagawa M., Okada M., Toshihiro W., et al. Ocular granulomatous meningoencephalomyelitis in a dog: magnetic resonance images and clinical findings. JVet Med Sci 2009, 71:233-237.
68. Smith R. Acase of ocular granulomatous meningoencephalitis in a German Shepherd dog presenting as bilateral uveitis. Aust Vet Pract 1995, 25:76-78.
69. Cordy D.R. Canine granulomatous meningoencephalomyelitis. Vet Pathol 1979, 16:325-333.
70. Braund K.G., Vandevelde M., Walker T.L. Granulomatous meningoencephalomyelitis in six dogs. JAm Vet Med Assoc 1978, 172:1195-1200.
71. Fankhauser R., Fatzer R., Luginbuhl H. Reticulosis of the central nervous system (CNS) in dogs. Adv Vet Sci Comp Med 1972, 16:35-72.
72. Koestner A. Primary lymphoreticuloses of the nervous system in animals. ActaNeuropathol Suppl 1975, 6:85-89.
73. Vandevelde M., Fatzer R., Fankhauser R. Immunohistological studies on primary reticulosis of the canine brain. Vet Pathol 1981, 18:577-588.
74. Suzuki M., Uchida K., Morozumi M., et al. Acomparative pathological study on granulomatous meningoencephalomyelitis and central malignant histiocytosis in dogs. JVet Med Sci 2003, 65:1319-1324.
75. Demierre S., Tipold A., Griot-Wenk M.E., et al. Correlation between the clinical course of granulomatous meningoencephalomyelitis in dogs and the extent of mast cell infiltration. Vet Rec 2001, 148:467-472.
76. Suzuki M., Uchida K., Morozumi M., et al. Acomparative pathological study on canine necrotizing meningoencephalitis and granulomatous meningoencephalomyelitis. JVet Med Sci 2003, 65:1233-1239.
77. Park E.S., Uchida K., Nakayama H. Comprehensive immunohistochemical studies on canine necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME). Vet Pathol 2012, 49:682-692.
78. Cordy D.R., Holliday T.A. Anecrotizing meningoencephalitis of pug dogs. Vet Pathol 1989, 26:191-194.
79. Flegel T., Henke D., Boettcher I.C., et al. Magnetic resonance imaging findings in histologically confirmed pug dog encephalitis. Vet Radiol Ultrasound 2008, 49:419-424.
80. Levine J.M., Fosgate G.T., Porter B., et al. Epidemiology of necrotizing meningoencephalitis in pug dogs. JVet Intern Med 2008, 22:961-968.
81. Uchida K., Hasegawa T., Ikeda M., et al. Detection of an autoantibody from Pug dogs with necrotizing encephalitis (pug dog encephalitis). Vet Pathol 1999, 36:301-307.
82. Young B., Levine J.L., Fosgate A., et al. Magnetic resonance imaging characteristics of necrotizing meningoencephalitis in pug dogs. JVet Intern Med 2009, 23(3):527-535.
83. Kobayashi Y., Ochiai K., Umemura T., et al. Necrotizing meningoencephalitis in pug dogs in Japan. JComp Pathol 1994, 110:129-136.
84. Summers B.A., Cummings J.F., de Lahunta A. Veterinary neuropathology 1995, Mosby, St Louis (MO).
85. Stalis I.H., Chadwick B., Dayrell-Hart B., et al. Necrotizing meningoencephalitis of Maltese dogs. Vet Pathol 1995, 32:230-235.
86. Cantile C., Chianini F., Arispici M., et al. Necrotizing meningoencephalitis associated with cortical hippocampal hamartia in a Pekingese dog. Vet Pathol 2001, 38:119-122.
87. Aresu L., D'Angelo A., Zanatta R., et al. Canine necrotizing encephalitis associated with antiglomerular basement membrane glomerulonephritis. JComp Pathol 2007, 136:279-282.
88. Park E.S., Uchida K., Nakayama H. Th1-, Th2-, and Th17-related cytokine and chemokine receptor mRNA and protein expression in the brain tissues, T cells, and macrophages of dogs with necrotizing and granulomatous meningoencephalitis. Vet Pathol 2013, 50:1127-1134.
89. Ducote J.M., Johnson K.E., Dewey C.W., et al. Computed tomography of necrotizing meningoencephalitis in 3 Yorkshire terriers. Vet Radiol Ultrasound 1999, 40:617-621.
90. Jull B.A., Merryman J.I., Thomas W.B., et al. Necrotizing encephalitis in a Yorkshire terrier. JAm Vet Med Assoc 1997, 211:1005-1007.
91. Kuwamura M., Adachi T., Yamate J., et al. Necrotising encephalitis in the Yorkshire terrier: a case report and literature review. JSmall Anim Pract 2002, 43:459-463.
92. Sawashima Y., Sawashima K., Aura Y., et al. Clinical and pathological findings of aYorkshire terrier affected with necrotizing encephalitis. JVet Med Sci 1996, 58:659-661.
93. Tipold A., Fatzer R., Jaggy A., et al. Necrotizing encephalitis in Yorkshire terriers. JSmall Anim Pract 1993, 34:623-628.
94. von Praun F., Matiasek K., Grevel V., et al. Magnetic resonance imaging and pathologic findings associated with necrotizing encephalitis in two Yorkshire terriers. Vet Radiol Ultrasound 2006, 47:260-264.
95. Timmann D., Konar M., Howard J., et al. Necrotising encephalitis in a French bulldog. JSmall Anim Pract 2007, 48:339-342.
96. Spitzbarth I., Schenk H.C., Tipold A., et al. Immunohistochemical characterization of inflammatory and glial responses in a case of necrotizing leucoencephalitis in a French bulldog. JComp Pathol 2010, 142:235-241.
97. Lotti D., Capucchio T., Gaidolfi E., et al. Necrotizing encephalitis in a Yorkshire terrier: clinical imaging, and pathological findings. Vet Radiol Ultrasound 1999, 40:622-626.
98. Lezmi S., Toussaint Y., Prata D., et al. Severe necrotizing encephalitis in a Yorkshire terrier: topographic and immunohistochemical study. JVet Med A Physiol Pathol Clin Med 2007, 54:186-190.
99. Nghiem P.P., Schatzberg S.J. Conventional and molecular diagnostic testing for the acute neurologic patient. JVet Emerg Crit Care (San Antonio) 2010, 20:46-61.
100. Thomas W.B. Inflammatory diseases of the central nervous system in dogs. Clin Tech Small Anim Pract 1998, 13:167-178.
101. Flegel T., Oevermann A., Oechtering G., et al. Diagnostic yield and adverse effects of MRI-guided free-hand brain biopsies through a mini-burr hole in dogs with encephalitis. JVet Intern Med 2012, 26:969-976.
102. Lamb C.R., Croson P.J., Cappellow R., et al. Magnetic resonance imaging findings in 25 dogs with inflammatory cerebrospinal fluid. Vet Radiol Ultrasound 2005, 46:17-22.
103. Plummer S.B., Wheeler S.J., Thrall D.E., et al. Computed tomography of primary inflammatory brain disorders in dogs and cats. Vet Radiol Ultrasound 1992, 33:307-312.
104. Speciale J., Van Winkle T.J., Steinberg S.A., et al. Computed tomography in the diagnosis of focal granulomatous meningoencephalitis: retrospective evaluation of three cases. JAm Anim Hosp Assoc 1992, 28:327-332.
105. Wolff C.A., Holmes S.P., Young B.D., et al. Magnetic resonance imaging for the differentiation of neoplastic, inflammatory, and cerebrovascular brain disease in dogs. JVet Intern Med 2012, 26:589-597.
106. Keenihan E.K., Summers B.A., David F.H., et al. Canine meningeal disease: associations between magnetic resonance imaging signs and histologic findings. Vet Radiol Ultrasound 2013, 54:504-515.
107. Cherubini G.B., Platt S.R., Anderson T.J., et al. Characteristics of magnetic resonance images of granulomatous meningoencephalomyelitis in 11 dogs. Vet Rec 2006, 159:110-115.
108. Mellema L.M., Samii V.F., Vernau K.M., et al. Meningeal enhancement on magnetic resonance imaging in 15 dogs and 3 cats. Vet Radiol Ultrasound 2002, 43:10-15.
109. Vite C.H., Cross J.R. Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats. Vet Radiol Ultrasound 2011, 52(Suppl 1):S23-31.
110. Lobetti R.G., Pearson J. Magnetic resonance imaging in the diagnosis of focal granulomatous meningoencephalitis in two dogs. Vet Radiol Ultrasound 1996, 37:424-427.
111. Kitagawa M., Kanayama K., Satoh T., et al. Cerebellar focal granulomatous meningoencephalitis in a dog: clinical findings and MR imaging. JVet Med A Physiol Pathol Clin Med 2004, 51:277-279.
112. Cherubini G.B., Platt S.R., Howson S., et al. Comparison of magnetic resonance imaging sequences in dogs with multi-focal intracranial disease. JSmall Anim Pract 2008, 49(12):634-640.
113. Kuwabara M., Tanaka S., Fujiwara K. Magnetic resonance imaging and histopathology of encephalitis in a Pug. JVet Med Sci 1998, 60:1353-1355.
114. Cherubini G.B., Mantis P., Martinez T.A., et al. Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats. Vet Radiol Ultrasound 2005, 46:384-387.
115. Rodenas S., Pumarola M., Gaitero L., et al. Magnetic resonance imaging findings in 40 dogs with histologically confirmed intracranial tumours. Vet J 2011, 187:85-91.
116. Kitagawa M., Okada M., Kanayama K., et al. Acanine case of necrotizing meningoencephalitis for long-term observation: clinical and MRI findings. JVet Med Sci 2007, 69:1195-1198.
117. Hasegawa T. Long-term management of necrotizing meningoencephalitis in a Pug dog. Canine Pract 2000, 25:20-22.
118. Jung D.I., Kang B.T., Park C., et al. Acomparison of combination therapy (cyclosporine plus prednisolone) with sole prednisolone therapy in 7 dogs with necrotizing meningoencephalitis. JVet Med Sci 2007, 69:1303-1306.
119. Bailey C., Higgins R. Characteristics of cerebrospinal fluid associated with canine meningoencephalomyelitis: a retrospective study. JAm Vet Med Assoc 1986, 188:418-421.
120. Bohn A.A., Wills T.B., West C.L., et al. Cerebrospinal fluid analysis and magnetic resonance imaging in the diagnosis of neurologic disease in dogs: a retrospective study. Vet Clin Pathol 2006, 35:315-320.
121. Tipold A., Pfister H., Zurbriggen A., et al. Intrathecal synthesis of major immunoglobulin classes in inflammatory diseases of the canine CNS. Vet Immunol Immunopathol 1994, 42:149-159.
122. Sorjonen D.C. Cerebrospinal fluid electrophoresis. Use in canine granulomatous meningoencephalomyelitis. Veterinary Medicine Report 1989, 1:399-403.
123. Sorjonen D.C. Total protein, albumin quota, and electrophoretic patterns in cerebrospinal fluid of dogs with central nervous system disorders. Am J Vet Res 1987, 48:301-305.
124. Shibuya M., Matsuki N., Fujiwara K., et al. Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis. JVet Med Sci 2007, 69:241-245.
125. Toda Y., Matsuki N., Shibuya M., et al. Glial fibrillary acidic protein (GFAP) and anti-GFAP autoantibody in canine necrotising meningoencephalitis. Vet Rec 2007, 161:261-264.
126. Duque C., Parent J., Bienzle D. The immunophenotype of blood and cerebrospinal fluid mononuclear cells in dogs. JVet Intern Med 2002, 16:714-719.
127. Koblik P.D., LeCouteur R.A., Higgins R.J., et al. CT-guided brain biopsy using a modified Pelorus Mark III stereotactic system: experience with 50 dogs. Vet Radiol Ultrasound 1999, 40:434-440.
128. Moissonnier P., Bordeau W., Delisle F., et al. Accuracy testing of a new stereotactic CT-guided brain biopsy device in the dog. Res Vet Sci 2000, 68:243-247.
129. Flegel T., Podell M., March P.A., et al. Use of a disposable real-time CT stereotactic navigator device for minimally invasive dog brain biopsy through a mini-burr hole. AJNR Am J Neuroradiol 2002, 23:1160-1163.
130. Giroux A., Jones J.C., Bøhn J.H., et al. Anew device for stereotactic CT-guided biopsy of the canine brain: design, construction, and needle placement accuracy. Vet Radiol Ultrasound 2002, 43:229-236.
131. Troxel M.T., Vite C.H. CT-guided stereotactic brain biopsy using the Kopf stereotactic system. Vet Radiol Ultrasound 2008, 49:438-443.
132. Chen A.V., Wininger F.A., Frey S., et al. Description and validation of a magnetic resonance imaging-guided stereotactic brain biopsy device in the dog. Vet Radiol Ultrasound 2012, 53:150-156.
133. Thomas W.B., Sorjonen D.C., Hudson J.A., et al. Ultrasound-guided brain biopsy in dogs. Am J Vet Res 1993, 54:1942-1947.
134. Harari J., Moore M.M., Leathers C.W., et al. Computed tomographic-guided free-hand needle biopsy of brain tumors in dogs. Progress Vet Neurology 1994, 4:41-44.
135. Klopp L.S., Ridgway M. Use of an endoscope in minimally invasive lesion biopsy and removal within the skull and cranial vault in two dogs and one cat. JAm Vet Med Assoc 2009, 234:1573-1577.
136. Vernau K.M., Higgins R.J., Bollen A.W., et al. Primary canine and feline nervous system tumors: Intraoperative diagnosis using the smear technique. Vet Pathol 2001, 38:47-57.
137. Radaelli S.T., Platt S.R. Bacterial meningoencephalomyelitis in dogs: a retrospective study. JVet Intern Med 2002, 16:159-163.
138. Greer K.A., Schatzberg S.J., Porter B.F., et al. Heritability and transmission analysis of necrotizing meningoencephalitis in the pug. Res Vet Sci 2009, 86(3):438-442.
139. Barber R.M., Schatzberg S.J., Corneveaux J.J., et al. Identification of risk loci fornecrotizing meningoencephalitis in pug dogs. JHered 2011, 102(S1):S40-46.
140. Pedersen N., Liu H., Millon L., et al. Dog leukocyte antigen class II-associated genetic risk testing for immune disorders of dogs: simplified approaches using Pug dog necrotizing meningoencephalitis as a model. JVet Diagn Invest 2011, 23:68-76.
141. Storch M.K., Bauer J., Linington C., et al. Cortical demyelination can be modeled inspecific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related. JNeuropathol Exp Neurol 2006, 65:1137-1142.
142. Bar-Or A. The immunology of multiple sclerosis. Semin Neurol 2008, 28:29-45.
143. Viviano K.R. Update on immunosuppressive therapies for dogs and cats. Vet Clin Small Anim 2013, 43:1149-1170.
144. Flegel T., Boettcher I.C., Matiasek K., et al. Comparison of oral administration of lomustine and prednisolone or prednisolone alone as treatment for granulomatous meningoencephalomyelitis or necrotizing encephalitis in dogs. JAm Vet Med Assoc 2011, 238:337-345.
145. Gregor C.R., Stewar A., Sturges B., et al. Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy. Transplan Proceed 1998, 30:4143-4148.
146. Coates J.R., Barone G., Dewey C.W., et al. Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004). JVet Intern Med 2007, 21:100-106.
147. Nuhsbaum M.T., Powell C.C., Gionfriddo J.R., et al. Treatment of granulomatous meningoencephalomyelitis in a dog. Vet Ophthalmol 2002, 5:29-33.
148. Menaut P., Landart J., Behr S., et al. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside. Vet Rec 2008, 162:241-245.
149. Smith P.M., Stalin C.E., Shaw D., et al. Comparison of two regimens for the treatment of meningoencephalomyelitis of unknown etiology. JVet Intern Med 2009, 23:520-526.
150. Behr S., Llabres-Dias F.J., Radaelli S.T. Treatment of meningoencephalitis of unknown origin in a dog. Vet Rec 2009, 164:627-629.
151. Lowrie M., Smith P.M., Garosi L. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol. Vet Rec 2013, 172:527-534.
152. de Stefani A, De Risio L, Matiasek K. Intravenous cytosine arabinoside in the emergency treatment of 9 dogs with central nervous system inflammatory disease of unknown etiology. In: 20th Annual Symposium of the European College of Veterinary Neurology. Bern (Switzerland), 2007. p. 508.
153. Uriarte JL, Thibaud K, Gnirs S. Lomustine treatment in noninfectious meningoencephalitis in 8 dogs. In: 20th Annual Symposium of the European College of Veterinary Neurology. Bern (Switzerland), 2007. p. 508.
154. Feliu-Pascual AL, Matiasek K, de Stefani A, etal. Efficacy of mycophenolate mofetil for the treatment of presumptive granulomatous meningoencephalomyelitis: preliminary results. In: 20th Annual Symposium of the European College of Veterinary Neurology. Bern (Switzerland), 2007. p. 509.
155. Wong M.A., Hopkins A.L., Meeks J.C., et al. Evaluation of treatment with a combination of azathioprine and prednisone in dogs with meningoencephalomyelitis of undetermined etiology: 40 cases (2000-2007). JAm Vet Med Assoc 2010, 237:929-935.
156. Gnirs K. Ciclosporin treatment of suspected granulomatous meningoencephalitis in three dogs. JSmall Anim Pract 2006, 47:201-206.
157. Adamo P.F., Rylander H., Adams W.M. Cyclosporin use in multidrug therapy for meningoencephalomyelitis of unknown aetiology in dogs. JSmall Anim Pract 2007, 48(9):486-496.
158. Adamo F.P., O'Brien R.T. Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs. JAm Vet Med Assoc 2004, 225:1211-1216.
159. Pakozdy A., Leschnik M., Kneissl S., et al. Improved survival time in dogs with suspected GME treated with ciclosporin. Vet Rec 2009, 164:89-91.
160. Scott-Moncrieff J.C., Chan T.C., Samuels M.L., et al. Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs. Cancer Chemother Pharmacol 1991, 29:13-18.
161. Crook K.I., Early P.J., Messenger K.M., et al. The pharmacokinetics of cytarabine in dogs when administered via subcutaneous and continuous intravenous infusion rates. JVet Pharmacol Ther 2013, 36:408-411.
162. Bateman S.W., Parent J.M. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995). JAm Vet Med Assoc 1999, 215:1463-1468.